<DOC>
	<DOC>NCT01735188</DOC>
	<brief_summary>Primary objective: Characterize the natural history of MoCD type A in terms of survival Secondary objectives: 1. Evaluate blood and urine for biochemical markers 2. Evaluate head circumference, seizure activity and neurologic outcomes 3. To evaluate brain MRI 4. Compare blood and urine analysis, head circumference, seizure activity and neurologic outcomes to MRI findings</brief_summary>
	<brief_title>A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies</brief_title>
	<detailed_description />
	<mesh_term>Metal Metabolism, Inborn Errors</mesh_term>
	<mesh_term>Amino Acid Metabolism, Inborn Errors</mesh_term>
	<mesh_term>Molybdenum</mesh_term>
	<criteria>1. Both living and deceased patients of any age will be considered for study inclusion. 2. Diagnosis of MoCD or isolated SOX deficiency 3. Documented informed consent 1. MoCD Type A patient who was in Study ALXMCD501 2. Deceased patients with unknown genotype (as of Amendment 4)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Natural history study</keyword>
</DOC>